Friday EOW update — HIMS pivot held, LLY-leader-bounce complicates frame

Update

Friday EOW update — HIMS pivot held, LLY-leader-bounce complicates frame

  • Type: refresh (subtype: weekly)
  • event_id: 2026-05-01-protein-economy-friday-eow
  • Source: Production refresh — 2026-05-01-protein-economy
  • Shift: HIMS at RSI 58 — close to but not yet at the <55 entry zone. The cohort (MRK/JNJ/GILD/AMGN/MDT/ABT/DXCM) confirms drug-side compression, but LLY specifically bounced +6.4% — partially weakens the "channel beats SKU" frame. CVS surfaced as a regulatory-safer adjacent distribution vehicle (+16.5% 30D, RSI 65). Wider consumer cohort (LULU/NKE/CMG/DPZ) rolling — cross-thesis confirmation that "channel beats SKU" generalizes beyond GLP-1.
  • Effect on thesis: Hold pivot, no entry yet. Re-examine LLY frame after next earnings. Add CVS as watch-for. Status remains monitoring.
  • Per-ticker: HIMS → (waiting on entry, RSI 58), LLY ↑ (bounce held, frame complication), NVO → (no current data — cohort rolling), BRBR → (sideways, killed-thesis benchmark), CVS ↑ (sleeper distribution vehicle), broader pharma cohort ↓ (de-rate confirmed)
6 events
DateTypeEvent
May 1 ArticleChannel Beats SKU — Does the GLP-1 Distribution Thesis Generalize? Apr 12 SourceGLP-1 Protein Cultural Signals Apr 27 ReferenceYOLO Playbook Jun 16 ScanHealthcare Scan Apr 29 Article🔬 Thesis Pulse Apr 28 ScanBiotech Scan

No direct external sources are attached to this read.